TECH NEWS
The vendor that used to be the customer: Pivot Path’s $27M spinout story
Every pharma CIO has sat through the same vendor pitch: a platform built by people who understand the idea of a regulated environment, but who have never actually owned a deviation, fronted an inspection, or explained a missing signature to an FDA auditor. Pivot Path breaks that pattern by inverting